156 related articles for article (PubMed ID: 22001608)
21. The effects of salmon calcitonin-induced hypocalcemia on bone metabolism in ovariectomized rats.
Davey RA; Morris HA
J Bone Miner Metab; 2005; 23(5):359-65. PubMed ID: 16133685
[TBL] [Abstract][Full Text] [Related]
22. Isolation, characterization, and stability of positional isomers of mono-PEGylated salmon calcitonins.
Lee KC; Moon SC; Park MO; Lee JT; Na DH; Yoo SD; Lee HS; DeLuca PP
Pharm Res; 1999 Jun; 16(6):813-8. PubMed ID: 10397599
[TBL] [Abstract][Full Text] [Related]
23. Response of trabecular bone, thyroid C and follicular cells to synthetic salmon calcitonin in middle-aged orchidectomized male rats.
Filipović B; Šošić-Jurjević B; Ajdžanović V; Živanović J; Ristić N; Trifunović S; Milošević V
J Anat; 2017 Jun; 230(6):787-795. PubMed ID: 28220476
[TBL] [Abstract][Full Text] [Related]
24. Ultrastructural properties of bone mineral of control and tiludronate-treated osteoporotic rat.
Rohanizadeh R; LeGeros RZ; Bohic S; Pilet P; Barbier A; Daculsi G
Calcif Tissue Int; 2000 Oct; 67(4):330-6. PubMed ID: 11000348
[TBL] [Abstract][Full Text] [Related]
25. Effects of continuous and cyclic nasal calcitonin administration in ovariectomized women.
Fioretti P; Gambacciani M; Taponeco F; Melis GB; Capelli N; Spinetti A
Maturitas; 1992 Dec; 15(3):225-32. PubMed ID: 1465036
[TBL] [Abstract][Full Text] [Related]
26. Calcitonin load test to assess the efficacy of salmon calcitonin.
Stepan JJ; Zikán V
Clin Chim Acta; 2003 Oct; 336(1-2):49-55. PubMed ID: 14500034
[TBL] [Abstract][Full Text] [Related]
27. Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept for potent calcitonin analogues.
Taylor JW; Jin QK; Sbacchi M; Wang L; Belfiore P; Garnier M; Kazantzis A; Kapurniotu A; Zaratin PF; Scheideler MA
J Med Chem; 2002 Feb; 45(5):1108-21. PubMed ID: 11855991
[TBL] [Abstract][Full Text] [Related]
28. Identification of the modifying sites of mono-PEGylated salmon calcitonins by capillary electrophoresis and MALDI-TOF mass spectrometry.
Na DH; Park MO; Choi SY; Kim YS; Lee SS; Yoo SD; Lee HS; Lee KC
J Chromatogr B Biomed Sci Appl; 2001 Apr; 754(1):259-63. PubMed ID: 11318423
[TBL] [Abstract][Full Text] [Related]
29. Effects of nasal administration of calcitonin in oophorectomized women: 2-year controlled double-blind study.
Grigoriou O; Papoulias I; Vitoratos N; Papadias C; Konidaris S; Antoniou G; Chryssikopoulos A
Maturitas; 1997 Dec; 28(2):147-51. PubMed ID: 9522322
[TBL] [Abstract][Full Text] [Related]
30. Prevention of osteoporosis with nasal salmon calcitonin: effect of anti-salmon calcitonin antibody formation.
Reginster JY; Gaspar S; Deroisy R; Zegels B; Franchimont P
Osteoporos Int; 1993 Sep; 3(5):261-4. PubMed ID: 8400608
[TBL] [Abstract][Full Text] [Related]
31. An acute and focal osteopenia model using ovariectomized rats: a rapid detection of the protective effect of salmon calcitonin.
Nakamuta H; Sasaki M; Ichikawa M; Koida M
Biol Pharm Bull; 1993 Mar; 16(3):325-7. PubMed ID: 8364484
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of diphosphonate-blocked bone mineralization. Evidence that calcitonin promotes mineralization.
Boris A; Hurley JF; Trmal T; Mallon JP; Matuszewski DS
Acta Endocrinol (Copenh); 1979 Jun; 91(2):351-61. PubMed ID: 463451
[TBL] [Abstract][Full Text] [Related]
33. Hypocalcemic effect of salmon calcitonin following single and repeated nasal and intravenous administration in young rabbits.
Schipper NG; Romeijn SG; Verhoef J; Merkus FW
Calcif Tissue Int; 1994 Jan; 54(1):50-5. PubMed ID: 8118754
[TBL] [Abstract][Full Text] [Related]
34. Effects of salmon calcitonin suppositories in the prevention of bone loss in oophorectomized women.
Polatti F; Perotti F; Angelini GP; Vassellatti D; Rapisardi I
Maturitas; 1993 Dec; 18(1):73-6. PubMed ID: 8107619
[TBL] [Abstract][Full Text] [Related]
35. Calcitonin and calcium combined therapy in osteoporosis: effects on vertebra trabecular bone density.
Ozoran K; Paker N; Başgöze O; Hasçelik Z; Erzen C; Narman S; Ozker R
J Int Med Res; 1989; 17(4):395-400. PubMed ID: 2792558
[TBL] [Abstract][Full Text] [Related]
36. Transdermal administration of salmon calcitonin by pulse depolarization-iontophoresis in rats.
Nakamura K; Katagai K; Mori K; Higo N; Sato S; Yamamoto K
Int J Pharm; 2001 May; 218(1-2):93-102. PubMed ID: 11337153
[TBL] [Abstract][Full Text] [Related]
37. Proliferative pituitary lesions in rats treated with salmon or porcine calcitonin.
Brown WR; Fetter AD; Van Ryzin RJ; Langloss JM
Toxicol Pathol; 1993; 21(1):81-6. PubMed ID: 8378709
[TBL] [Abstract][Full Text] [Related]
38. Induction of hypocalcemia by intracerebroventricular injection of calcitonin: evidence for control of blood calcium by the nervous system.
Goltzman D; Tannenbaum GS
Brain Res; 1987 Jul; 416(1):1-6. PubMed ID: 3620946
[TBL] [Abstract][Full Text] [Related]
39. Prevention of ovariectomy osteopenia in rats after vaginal administration of Hyaff 11 microspheres containing salmon calcitonin.
Bonucci E; Ballanti P; Ramires PA; Richardson JL; Benedetti LM
Calcif Tissue Int; 1995 Apr; 56(4):274-9. PubMed ID: 7767837
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoid-induced secondary osteopenia in female rats: a time course study as compared with ovariectomy-induced osteopenia and response to salmon calcitonin.
Nitta T; Fukushima T; Nakamuta H; Koida M
Jpn J Pharmacol; 1999 Mar; 79(3):379-86. PubMed ID: 10230867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
